This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: University of Utah Research Foundation, Cephalon, Inc., University of Hawai'i. Active years: 2011-2016.
Location History:
- Park City, UT (US) (2011)
- Honolulu, HI (US) (2016)
Company Filing History:
2 out of 1,685 
1 out of 248 
1 out of 267 
Years Active: 2011-2016
Title: Scott K Kuwada: Innovator in Pharmaceutical Chemistry
Introduction
Scott K Kuwada is a notable inventor based in Honolulu, HI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating cancer. With a total of 2 patents, his work has the potential to impact cancer treatment methodologies.
Latest Patents
Kuwada's latest patents include innovative compounds and methods. One of his patents focuses on substituted aromatic sulfur compounds and their use in pharmaceutical compositions. These compounds are designed to treat or reduce the risk of peritoneal carcinomatosis in patients. Another patent details compositions and methods for inhibiting NF-κB mediated tumorigenicity and the adhesion-dependent survival of cancer cells. This work aims to inhibit cellular proliferation and metastasis, providing new avenues for cancer therapy.
Career Highlights
Throughout his career, Scott K Kuwada has worked with esteemed organizations such as the University of Utah Research Foundation and Cephalon, Inc. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Kuwada has collaborated with notable colleagues, including Craig A Zificsak and Bruce D Dorsey. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Scott K Kuwada's contributions to pharmaceutical chemistry and cancer treatment exemplify the importance of innovation in medicine. His patents and collaborations highlight his commitment to advancing healthcare solutions.